DRUG: Bright Minds Biosciences Inc. Stock

by  •  • Comments Off on DRUG: Bright Minds Biosciences Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 245.49
Enterprise Value ($M) n/a
Book Value ($M) 6.10
Book Value / Share 0.88
Price / Book n/a
NCAV ($M) 6.09
NCAV / Share 0.88
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.58
Return on Assets (ROA) -0.52
Return on Equity (ROE) -0.54

Liquidity (mrq)
Quick Ratio 35.08
Current Ratio 35.08

Balance Sheet (mrq) ($M)
Current Assets 6.27
Assets 6.28
Liabilities 0.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G Ra Capital Management, L.p. 6.60
11-06 13G/A Cormorant Asset Management, LP 17.26 24.63
11-05 13D/A McDonald Ian 24.40 -12.87
10-25 13G Commodore Capital Lp 9.00
10-23 13G Point72 Asset Management, L.P. 9.70
10-23 13G Logos Global Management LP 2.20
10-22 13G/A PFM Health Sciences, LP 0.00
10-16 13G Perceptive Advisors Llc 9.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-25 43,543 168,119 25.90
2024-11-22 69,415 238,464 29.11
2024-11-21 27,069 311,875 8.68
2024-11-20 20,890 84,306 24.78

(click for more detail)

Similar Companies
DNTH – Dianthus Therapeutics, Inc. DRMA – Dermata Therapeutics, Inc.
DRRX – DURECT Corporation DTIL – Precision BioSciences, Inc.
DWTX – Dogwood Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io